Children’s perceptions about medicines: individual differences and taste

Abstract

BackgroundBitter taste receptors are genetically diverse, so children likely vary in sensitivity to the “bad” taste of some pediatric formulations. Based on prior results that variation in a bitter taste receptor gene, TAS2R38, was related to solid (pill) formulation usage, we investigated whether this variation related to liquid formulation usage and young children’s reports of past experiences with medicines and whether maternal reports of these past experiences were concordant with those of their children.MethodsWe conducted retrospective interviews of 172 children 3 to 10 years old and their mothers (N = 130) separately in a clinical research setting about issues related to medication usage. Children were genotyped for the TASR38 variant A49P (alanine to proline at position 49). Children’s responses were compared with their TAS2R38 genotype and with maternal reports.ResultsChildren (>4 years) reported rejecting medication primarily because of taste complaints, and those with at least one sensitive TAS2R38 allele (AP or PP genotype) were more likely to report rejecting liquid medications than were those without a taster allele (AA genotype; χ2 = 5.72, df = 1, p = 0.02). Children’s and mothers’ reports of the children’s past problems with medication were in concordance (p = 0.03).ConclusionsIndividual differences in taste responses to medications highlight the need to consider children’s genetic variation and their own perceptions when developing formulations acceptable to the pediatric palate. Pediatric trials could systematically collect valid information directly from children and from their caregivers regarding palatability (rejection) issues, providing data to develop well-accepted pediatric formulations that effectively treat illnesses for all children.Trial RegistrationClinicaltrials.gov protocol registration system (NCT01407939). Registered 19 July 2011.

Variation in the Ability to Taste Bitter Thiourea Compounds: Implications for Food Acceptance, Dietary Intake, and Obesity Risk in Children

“…Lipchock and colleagues (86) hypothesized that bitter-taste sensitivity might impact children's willingness to accept liquid forms of medications. Children who had at least one bitter-sensitive allele at TAS2R38 reported being more likely to reject liquid medications (97) and were more likely to have consumed solid medication forms (i.e., pills or capsules) (86) compared to children with bitter-insensitive genotypes. Determining the most effective methods of blocking bitter taste in children's medications to improve palatability and compliance is a public health priority.…”

Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study

“…10,27 For oral medications, taste is a major reason children refuse medications overall. 2,3,28 Evaluating taste and palatability of psoriasis treatments in pediatric clinical trials may help clinicians address adherence issues. In our study, most patients found the taste of the apremilast tablet acceptable, and the high compliance rate observed is promising.…”

Paediatric Medicines: Formulation Considerations

“…It is well known that the paediatric use of off-label and unlicensed medicines are a reality and that there is a lack of medicines well studied for children. Although there are already some studies focusing on the perceptions of children [26][27][28], it is still important to improve our knowledge in this area. It is fundamental to develop research in order to understand attitudes and preferences of children and their caregivers with the aim of developing dosage forms and formulations which are children-friendly.…”